GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » PB Ratio

PharmX Technologies (ASX:PHX) PB Ratio : 1.11 (As of Apr. 25, 2024)


View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-25), PharmX Technologies's share price is A$0.03. PharmX Technologies's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.03. Hence, PharmX Technologies's PB Ratio of today is 1.11.

The historical rank and industry rank for PharmX Technologies's PB Ratio or its related term are showing as below:

ASX:PHX' s PB Ratio Range Over the Past 10 Years
Min: 0.38   Med: 1.22   Max: 4.29
Current: 1.11

During the past 13 years, PharmX Technologies's highest PB Ratio was 4.29. The lowest was 0.38. And the median was 1.22.

ASX:PHX's PB Ratio is ranked better than
75.63% of 595 companies
in the Healthcare Providers & Services industry
Industry Median: 2.23 vs ASX:PHX: 1.11

During the past 12 months, PharmX Technologies's average Book Value Per Share Growth Rate was -28.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 6.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -4.00% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -7.90% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of PharmX Technologies was 78.00% per year. The lowest was -76.10% per year. And the median was -13.15% per year.

Back to Basics: PB Ratio


PharmX Technologies PB Ratio Historical Data

The historical data trend for PharmX Technologies's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies PB Ratio Chart

PharmX Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 1.29 2.29 0.87 1.00

PharmX Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.59 0.87 0.82 1.00 1.52

Competitive Comparison of PharmX Technologies's PB Ratio

For the Health Information Services subindustry, PharmX Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmX Technologies's PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's PB Ratio distribution charts can be found below:

* The bar in red indicates where PharmX Technologies's PB Ratio falls into.



PharmX Technologies PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

PharmX Technologies's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.03/0.027
=1.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


PharmX Technologies  (ASX:PHX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


PharmX Technologies PB Ratio Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmX Technologies (ASX:PHX) Business Description

Traded in Other Exchanges
N/A
Address
17 Castlereagh Street, Level 11, Sydney, NSW, AUS, 2000
PharmX Technologies Ltd Formerly Corum Group Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. the company discontinued the e-commerce business in 2022.